HYMAN CHARLES D - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 64 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
HYMAN CHARLES D ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2018$16,000
-30.4%
30,0000.0%0.00%
-33.3%
Q4 2017$23,000
-46.5%
30,0000.0%0.00%
-40.0%
Q3 2017$43,000
-46.9%
30,0000.0%0.01%
-50.0%
Q2 2017$81,000
-33.1%
30,0000.0%0.01%
-37.5%
Q1 2017$121,000
-4.0%
30,0000.0%0.02%
-11.1%
Q4 2016$126,000
-38.2%
30,0000.0%0.02%
-40.0%
Q3 2016$204,000
+9.7%
30,000
-6.5%
0.03%
+7.1%
Q2 2016$186,000
-17.0%
32,1000.0%0.03%
-20.0%
Q1 2016$224,00032,1000.04%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q1 2017
NameSharesValueWeighting ↓
IMS Capital Management 624,673$481,0000.30%
WEDBUSH SECURITIES INC 98,255$76,0000.01%
Paulson Wealth Management Inc. 11,250$9,0000.01%
Indiana Trust & Investment Management CO 19,250$15,0000.01%
HYMAN CHARLES D 30,000$23,0000.00%
Baker Brothers Advisors 331,393$255,0000.00%
Virtu Financial LLC 41,079$32,0000.00%
WELCH & FORBES LLC 100,393$78,0000.00%
BOSTON FINANCIAL MANGEMENT LLC 42,424$33,0000.00%
Valeo Financial Advisors, LLC 5,750$4,0000.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders